- Home
- ETNB vs CC Comparison
ETNB vs CC Comparison
Compare ETNB & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- CC
- Stock Information
- Founded
- ETNB 2018
- CC 2014
- Country
- ETNB United States
- CC United States
- Employees
- ETNB 93
- CC N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- ETNB Health Care
- CC Industrials
- Exchange
- ETNB Nasdaq
- CC Nasdaq
- Market Cap
- ETNB 2.2B
- CC 2.3B
- IPO Year
- ETNB 2019
- CC N/A
- Fundamental
- Price
- ETNB $14.83
- CC $15.08
- Analyst Decision
- ETNB Buy
- CC Buy
- Analyst Count
- ETNB 10
- CC 8
- Target Price
- ETNB $22.31
- CC $18.13
- AVG Volume (30 Days)
- ETNB 9.5M
- CC 2.9M
- Earning Date
- ETNB 11-06-2025
- CC 11-03-2025
- Dividend Yield
- ETNB N/A
- CC 2.32%
- EPS Growth
- ETNB N/A
- CC N/A
- EPS
- ETNB N/A
- CC N/A
- Revenue
- ETNB N/A
- CC $5,850,000,000.00
- Revenue This Year
- ETNB N/A
- CC $4.91
- Revenue Next Year
- ETNB N/A
- CC $4.73
- P/E Ratio
- ETNB N/A
- CC N/A
- Revenue Growth
- ETNB N/A
- CC 0.62
- 52 Week Low
- ETNB $4.16
- CC $9.13
- 52 Week High
- ETNB $15.06
- CC $22.38
- Technical
- Relative Strength Index (RSI)
- ETNB 79.17
- CC 43.26
- Support Level
- ETNB $14.67
- CC $15.25
- Resistance Level
- ETNB $14.93
- CC $16.41
- Average True Range (ATR)
- ETNB 0.09
- CC 0.77
- MACD
- ETNB 0.06
- CC -0.30
- Stochastic Oscillator
- ETNB 41.03
- CC 7.28
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.